ID

31996

Descripción

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon; ODM derived from: https://clinicaltrials.gov/show/NCT01119274 Sponsor: Utrecht Institute for Pharmaceutical Sciences Collaborators: Utrecht University Leiden University Medical Center Erasmus Medical Center University of Ulm Newcastle University University of Liverpool LGC Limited Uppsala University Democritus University of Thrace Elisabethinen Hospital Information provided by (Responsible Party): Anke-Hilse Maitland-van der Zee, Utrecht Institute for Pharmaceutical Sciences

Link

https://clinicaltrials.gov/show/NCT01119274

Palabras clave

Versiones (1)
  1. 10/10/18 10/10/18 -
Titular de derechos de autor

Anke-Hilse Maitland-van der Zee, PharmD, PhD, Utrecht Institute for Pharmaceutical Sciences

Subido en

10 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

Inglés

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
Descripción

Venous thromboembolism, atrial fibrillation requiring coumarin therapy, target inr in the low intensity range

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1861172
UMLS CUI [1,2]
C0686904
UMLS CUI [1,3]
C0010206
UMLS CUI [2,1]
C0004238
UMLS CUI [2,2]
C0686904
UMLS CUI [2,3]
C0010206
UMLS CUI [3,1]
C1521840
UMLS CUI [3,2]
C0525032
age ≥ 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ability to attend scheduled visits
Descripción

Ability to attend scheduled visits

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2827364
UMLS CUI [1,2]
C0085732
signed informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of a mechanical heart valve
Descripción

Presence of a mechanical heart valve

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0493527
severe cognitive impairment
Descripción

Severe cognitive impairment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3554639
known genotype cyp2c9 or vkorc1 at start of the study
Descripción

Known genotype cyp2c9 or vkorc1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1332829
UMLS CUI [2]
C1428184
previous or current treatment with any coumarin
Descripción

Previous or current treatment with any coumarin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010206
UMLS CUI [1,2]
C2827774
UMLS CUI [2,1]
C0010206
UMLS CUI [2,2]
C1514463
pregnancy or lactation
Descripción

Pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0022925
non-eligible subject
Descripción

Ineligibility

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512714
Volver a la parte superior de la página

Similar models

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Venous thromboembolism, atrial fibrillation requiring coumarin therapy, target inr in the low intensity range
Item
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
boolean
C1861172 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0010206 (UMLS CUI [1,3])
C0004238 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0010206 (UMLS CUI [2,3])
C1521840 (UMLS CUI [3,1])
C0525032 (UMLS CUI [3,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Ability to attend scheduled visits
Item
ability to attend scheduled visits
boolean
C2827364 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Presence of a mechanical heart valve
Item
presence of a mechanical heart valve
boolean
C0493527 (UMLS CUI [1])
Severe cognitive impairment
Item
severe cognitive impairment
boolean
C3554639 (UMLS CUI [1])
Known genotype cyp2c9 or vkorc1
Item
known genotype cyp2c9 or vkorc1 at start of the study
boolean
C1332829 (UMLS CUI [1])
C1428184 (UMLS CUI [2])
Previous or current treatment with any coumarin
Item
previous or current treatment with any coumarin
boolean
C0010206 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0010206 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
Ineligibility
Item
non-eligible subject
boolean
C1512714 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial